| Standard Type | Standard Units | Activity Comment |
|---|---|---|
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000386857 uM | Activity at 0.0001060182 uM | Activity at 0.0001896372 uM | Activity at 0.0004510146 uM | Activity at 0.0007501981 uM | Activity at 0.0009728036 uM | Activity at 0.00288 uM | Activity at 0.00508 uM | Activity at 0.00871 uM | Activity at 0.015 uM | Activity at 0.026 uM | Activity at 0.053 uM | Activity at 0.079 uM | Activity at 0.232 uM | Activity at 0.457 uM | Activity at 0.692 uM | Activity at 1.068 uM | Activity at 2.292 uM | Activity at 3.859 uM | Activity at 11.39 uM | Activity at 17.02 uM | Activity at 25.62 uM | Activity at 57.25 uM | Activity at 87.55 uM | Activity at 183.4 uM | Activity at 286.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -6.75 | 4.9549 | 0.9727 | 0.0901 | 17.5 | 4 | 0 0 0 1 | 8.9408 | 15.9527 | -1.5916 | 1.4969 | 8.9408 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -5.3 | 4.095 | 0.9996 | 5.5 | -7.7823 | 4 | 0 0 0 1 | -11.1081 | -7.5736 | -7.7353 | 5.034 | -11.1081 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -5.15 | 4.9549 | 0.907 | -15.9207 | 9.5 | 4 | 0 0 0 1 | 17.8725 | 5.2874 | 13.9021 | -13.6839 | 17.8725 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Activator | 35.4813 | 46.4095 | 0 | Single point of activity | -4.45 | 2.5884 | 1 | 45.9404 | -0.4691 | 3 | 1 0 0 0 | 35.593 | 40.1678 | -0.3909 | 1.933 | 35.593 | QC'd by Sytravon | |||||||||||||||||||||||
| Activator | 39.8107 | 72.2646 | 0 | Single point of activity | -4.4 | 4.9549 | 0.9515 | 68.1912 | -4.0733 | 3 | 0 0 0 0 | 58.0117 | 5.8738 | -9.2278 | -8.5224 | 58.0117 | QC'd by Sytravon | |||||||||||||||||||||||
| Activator | 14.1254 | 45.3319 | 0 | Partial curve; partial efficacy; poor fit | -4.85 | 2.4064 | 0.9982 | 40.7728 | -4.5591 | 2.4 | 1 0 0 0 | 40.0933 | -24.9557 | -3.8845 | 11.5254 | 40.0933 | QC'd by Sytravon | |||||||||||||||||||||||
| Inactive | 0 | -5.75 | 4.9549 | 0.9291 | -20.6086 | 33.1545 | 4 | 1 0 0 0 | -12.8464 | 45.4569 | 28.2161 | -28.42 | -12.8464 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.35 | 4.9549 | 0.855 | -24.2184 | -0.5 | 4 | 0 0 0 0 | -18.932 | -3.6477 | -2.409 | 4.988 | -18.932 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.7 | 3.6272 | 0.8625 | 15 | -8.5523 | 4 | 0 0 0 0 | 14.477 | -2.951 | -13.7936 | -5.9646 | 14.477 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -6.7 | 4.9549 | 0.6637 | 3 | -16.864 | 4 | 0 0 0 0 | 8.8169 | -15.72 | 6.3794 | -6.3599 | 8.8169 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 2.4064 | 0.9999 | 21.5 | -2.4101 | 4 | 1 0 0 0 | 20.2184 | 33.3778 | -2.4251 | 3.5771 | 20.2184 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.4 | 4.9549 | 0.8117 | 2.5 | -8.345 | 4 | 0 0 0 0 | 1.096 | -8.966 | -5.5054 | -11.1209 | 1.096 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Activator | 39.8107 | 38.7945 | 0 | Single point of activity | -4.4 | 4.9549 | 0.6241 | 41.7557 | 2.9612 | 3 | 0 0 0 0 | 36.2039 | 21.355 | -6.3904 | -4.5325 | 36.2039 | QC'd by Sytravon | |||||||||||||||||||||||
| Inactive | 0 | -6.05 | 4.095 | 0.9994 | -6.0518 | 20 | 4 | 0 0 0 1 | 20.5156 | 19.7377 | 1.4122 | -6.2932 | 20.5156 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -5.2 | 4.095 | 1 | 10.5 | -10.1683 | 4 | 1 0 0 1 | -15.9884 | 36.1362 | -10.1402 | 8.7939 | -15.9884 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -6.5 | 1.3905 | 0.9999 | -24.241 | 0.2745 | 4 | 0 0 0 1 | -5.5981 | -4.3546 | -20.7587 | -23.9509 | -5.5981 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -6.8 | 4.9549 | 0.711 | -2.4459 | 21 | 4 | 0 0 0 0 | -3.3453 | 17.3219 | -9.9549 | 5.5495 | -3.3453 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Activator | 39.8107 | 47.809 | 0 | Partial curve; partial efficacy; poor fit | -4.4 | 4.9549 | 0.5212 | 50.2399 | 2.4309 | 2.4 | 0 0 0 0 | 43.4722 | 30.2363 | -10.9855 | -11.5143 | 43.4722 | QC'd by Sytravon | |||||||||||||||||||||||
| Activator | 22.3872 | 75.5081 | 0 | Partial curve; high efficacy; poor fit | -4.65 | 1.9673 | 0.9829 | 96.5324 | 21.0243 | 2.3 | 0 0 0 0 | 86.4985 | 26.0932 | 16.3365 | 36.2613 | 86.4985 | QC'd by Sytravon | |||||||||||||||||||||||
| Inactive | 0 | -6.8 | 4.9549 | 0.7429 | -1 | -13.0738 | 4 | 0 0 0 0 | 1.8063 | -11.3115 | 0.8702 | -5.1757 | 1.8063 | QC'd by Sytravon |
| Standard Type | Standard Units | Activity Comment |
|---|---|---|
| Inhibition | % | Active |
| Inhibition | % | Active |
| Inhibition | % | Active |
| Inhibition | % | Active |
| Inhibition | % | Active |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 60 | IC50 | = | 60000 | nM |
| 0.31 | IC50 | = | 310 | nM |
| Z_SCORE |
|---|
| 2.91 |
| -0.56 |
| 0.61 |
| 2.15 |
| 0.54 |
| -0.32 |
| 1.12 |
| -0.07 |
| 0.61 |
| 1.55 |
| -0.77 |
| -0.76 |
| -2.08 |
| 0.67 |
| -0.35 |
| 0.17 |
| -1.42 |
| -0.64 |
| -5.35 |
| 1.42 |
| Standard Type | Standard Units | Activity Comment |
|---|---|---|
| Inhibition | % | Active |
| Standard Type | Standard Units | Activity Comment |
|---|---|---|
| Inhibition | % | Active |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 89 | % |
| Standard Type | Activity Comment |
|---|---|
| Activity | Dose-dependent effect |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0001000000 uM | Activity at 0.0003000000 uM | Activity at 0.0006116734 uM | Activity at 0.00133 uM | Activity at 0.00297 uM | Activity at 0.00673 uM | Activity at 0.015 uM | Activity at 0.033 uM | Activity at 0.075 uM | Activity at 0.167 uM | Activity at 0.369 uM | Activity at 0.412 uM | Activity at 0.836 uM | Activity at 1.842 uM | Activity at 2.061 uM | Activity at 4.179 uM | Activity at 9.216 uM | Activity at 20.61 uM | Activity at 46.08 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 4.095 | 0.5622 | -0.5 | -17.4055 | 4 | 1 0 0 0 0 0 1 0 0 0 0 0 0 0 | 4.0358 | -8.1088 | -16.5879 | -0.7265 | -5.6584 | 4.373 | 0.1327 | -9.7032 | 0.3685 | 4.1527 | -0.141 | -3.5272 | -0.9713 | -9.3203 | 4.0358 | QC'd by NIEHS/NTP | |||||||||||
| Activator | 15.8489 | 52.3975 | 0 | Single point of activity | -4.8 | 0.4 | 0.5108 | 48.9806 | -3.4169 | 3 | 0 0 0 0 0 1 0 0 0 0 0 1 0 1 0 | 38.0621 | 2.0116 | -8.9739 | -7.0623 | 0 | -7.0944 | -39.2396 | 0 | 18.7338 | 25.7808 | 0 | 0 | -59.5394 | 11.6237 | 48.2153 | 38.0621 | QC'd by NIEHS | ||||||
| Inactive | 0 | 4 | -1.0832 | -10.8974 | 1.0031 | -11.058 | -11.888 | 3.6568 | 0.9182 | 5.3174 | 0.029 | -1.4893 | 2.1711 | 3.0788 | -19.8367 | -2.8584 | -1.0832 | QC'd by NIEHS/NTP | ||||||||||||||||
| Inactive | 0 | 4 | 2.4598 | 2.223 | -1.6367 | 8.778 | -0.1138 | 9.2269 | 3.4407 | 11.6742 | -2.1465 | 11.8823 | -1.8078 | -2.083 | 3.7825 | 4.4909 | 2.4598 | QC'd by NIEHS | ||||||||||||||||
| Inactive | 0 | 1.8579 | 0.4575 | 4.5 | -21.0899 | 4 | 0 0 0 0 0 0 0 0 0 0 0 0 0 0 | 12.886 | -15.9083 | 0.1018 | 0.3771 | -0.0246 | 7.9993 | -3.797 | 13.0973 | 11.6372 | 8.3022 | -2.6663 | 9.3202 | -2.3421 | -0.2854 | 12.886 | QC'd by NIEHS/NTP | |||||||||||
| Inactive | 0 | 4.9549 | 0.5492 | -6.7707 | 1.5 | 4 | 0 0 0 0 0 0 0 0 0 0 1 0 0 1 | 1.3669 | -1.0856 | -0.7765 | 1.1242 | 1.7058 | 0.7901 | -1.9869 | 6.0901 | 5.2659 | 3.2331 | -7.9279 | -28.3694 | -1.3017 | -10.2255 | 1.3669 | QC'd by NIEHS/NTP | |||||||||||
| Inactive | 0 | 4 | -5.5826 | -4.0359 | -4.4476 | -11.3473 | -11.9097 | -1.5507 | -10.1535 | -3.3626 | 1.3234 | -0.4426 | -13.9824 | -5.2512 | -18.0387 | -15.3022 | -5.5826 | QC'd by NIEHS/NTP | ||||||||||||||||
| Inhibitor | 39.8107 | 51.9004 | 20 | Partial curve; partial efficacy | -4.4 | 3.99 | 0.9828 | -50.1381 | 1.7623 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 0 0 0 | -49.4594 | 3.1993 | -0.0269 | 2.7134 | -1.9807 | 5.2946 | 0.2133 | -0.1387 | -0.2625 | 2.4708 | 0.1777 | 2.5372 | 0.4925 | -30.4729 | -49.4594 | QC'd by NIEHS/NTP | |||||||
| Inactive | 0 | 2.3332 | 0.6977 | -10.8456 | 1 | 4 | 0 0 0 0 0 0 1 0 0 0 0 1 0 1 | -1.1266 | -1.4611 | 1.2528 | -0.0369 | 0.0295 | 5.5889 | -3.0357 | 6.7506 | 4.5747 | -1.4797 | -0.1821 | -9.6414 | -1.4402 | -9.8713 | -1.1266 | QC'd by NIEHS/NTP | |||||||||||
| Inactive | 0 | 4 | 14.6008 | 0.5397 | -1.6708 | -0.413 | 0.9694 | 7.4259 | -2.2585 | 5.0869 | 7.9351 | -2.4752 | -5.636 | 5.3996 | 1.849 | -2.4871 | 14.6008 | QC'd by NIEHS/NTP | ||||||||||||||||
| Inactive | 0 | 0.7 | 0.5791 | -8.9231 | 4 | 4 | 0 0 0 0 0 0 1 0 0 0 0 0 0 1 | 2.8063 | 3.5153 | 5.1938 | 1.4116 | 6.3363 | 4.61 | 2.7429 | 12.4401 | 6.0481 | -0.1411 | 0.3707 | -1.4781 | 2.4968 | -5.7693 | 2.8063 | QC'd by NIEHS/NTP | |||||||||||
| Inactive | 0 | 4 | -17.8369 | -10.5115 | -2.5586 | -8.8158 | -26.0957 | -0.4819 | -9.7892 | -2.0149 | 0.2733 | 2.7166 | -17.2183 | -0.4759 | 1.0932 | -12.7028 | -17.8369 | QC'd by NIEHS/NTP | ||||||||||||||||
| Inactive | 0 | 4.9549 | 0.4427 | -9.7222 | -1.5 | 4 | 1 0 1 0 0 0 0 0 0 0 0 0 0 0 | -13.1018 | -5.5392 | 0.0068 | 7.7337 | 0.4588 | 4.0455 | -12.3759 | -6.5724 | 0.9218 | 1.9145 | -11.3469 | -7.6261 | -8.5179 | -8.6226 | -13.1018 | QC'd by NIEHS/NTP | |||||||||||
| Inactive | 0 | 3.132 | 0.7434 | -16.0784 | 1.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 0 0 1 | 3.9965 | 3.3921 | -1.1556 | 1.9715 | 2.0177 | 3.8894 | -2.609 | 2.8757 | 2.7238 | 4.1025 | -3.5446 | 2.1635 | -3.6983 | -12.982 | 3.9965 | QC'd by NIEHS/NTP | |||||||||||
| Inactive | 0 | 4 | 7.5372 | 4.3881 | -20.2011 | 5.5178 | -1.3758 | 2.0045 | -1.4401 | 4.9593 | -2.1122 | 1.3726 | -3.0011 | -3.0677 | 1.1883 | 2.1817 | 7.5372 | QC'd by NIEHS/NTP | ||||||||||||||||
| Inactive | 0 | 4 | 11.4525 | 0.2692 | -0.1403 | -0.3748 | -11.7489 | 2.8347 | -5.0546 | 16.8984 | 0.05 | 13.829 | -3.6094 | -0.5197 | 8.0326 | -1.5476 | 11.4525 | QC'd by NIEHS/NTP | ||||||||||||||||
| Inactive | 0 | 4 | 9.9936 | 1.7139 | 7.1691 | 6.3352 | -0.3432 | 9.148 | -5.8673 | -1.5641 | 12.611 | 1.8237 | 8.2616 | -0.6654 | 1.7363 | 2.6319 | 9.9936 | QC'd by NIEHS/NTP | ||||||||||||||||
| Inactive | 0 | 4 | 10.234 | 0.5252 | 1.3877 | -1.9626 | -0.942 | 5.6494 | -0.2769 | 11.7052 | 8.376 | 6.8657 | -0.149 | -0.1944 | 2.6788 | -6.4192 | 10.234 | QC'd by NIEHS/NTP | ||||||||||||||||
| Activator | 22.3872 | 33.8938 | 0 | Complete curve; partial efficacy; poor fit | -4.65 | 2.2526 | 0.7151 | 33.9963 | 0.1025 | 1.4 | 0 0 0 0 0 0 0 0 0 0 0 0 0 0 | 25.5224 | 0.4272 | -0.9219 | -0.128 | -2.1061 | 8.1765 | -1.5863 | -10.2265 | 12.1648 | 6.8628 | -0.3193 | -6.5155 | 17.6087 | 32.2689 | 25.5224 | QC'd by NIEHS/NTP | |||||||
| Inactive | 0 | 4 | 9.9848 | 5.5826 | 0.0396 | -1.5504 | -1.3004 | 3.295 | 3.9882 | 12.2742 | 8.0646 | 9.1192 | 2.03 | 1.2922 | 7.4225 | -2.9974 | 9.9848 | QC'd by NIEHS/NTP |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 12 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 80 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 42 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 46 | % |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 4 | IC50 | = | 4000 | nM | |
| 8 | IC50 | = | 8000 | nM | |
| 400 | IC50 | > | 400000 | nM | Outside typical range |
| 400 | IC50 | > | 400000 | nM | Outside typical range |
| 400 | IC50 | > | 400000 | nM | Outside typical range |
| 5 | IC50 | = | 5000 | nM | |
| 1.2 | IC50 | = | 1200 | nM | |
| 18 | IC50 | = | 18000 | nM | |
| 1600 | IC50 | > | 1600000 | nM | Outside typical range |
| 0.1 | IC50 | = | 100 | nM | |
| 400 | IC50 | > | 400000 | nM | Outside typical range |
| 5 | IC50 | = | 5000 | nM | |
| 30 | IC50 | = | 30000 | nM | |
| 3 | IC50 | = | 3000 | nM | |
| 10 | IC50 | = | 10000 | nM | |
| 30 | IC50 | = | 30000 | nM |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 7 | % |
| Phenotype | Potency | Efficacy | Analysis Comment | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.091 uM | Activity at 0.457 uM | Activity at 2.290 uM | Activity at 11.40 uM | Activity at 57.10 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 35.4813 | 61.0337 | Single point of activity | -4.45 | 2.4729 | 0.9637 | -64.3328 | -3.2991 | -3 | 0 0 0 0 0 | -49.8733 | 3.1174 | -5.94 | -7.2573 | -6.425 | -49.8733 | QC'd by "SigmaAldrich" | |
| Cytotoxic | 17.7828 | 67.679 | Single point of activity | -4.75 | 3.0654 | 0.9561 | -46.7507 | 20.9283 | -3 | 0 0 0 0 0 | -44.971 | 22.4039 | 11.1684 | 27.8842 | 7.6544 | -44.971 | QC'd by "SigmaAldrich" | |
| Inactive | 4 | 0 0 0 0 0 | -12.6837 | 16.8271 | 7.7283 | 13.5091 | 6.8161 | -12.6837 | QC'd by "SigmaAldrich" | |||||||||
| Inactive | 4 | 0 0 0 0 0 | -17.8401 | 10.8057 | -6.4777 | 0.5573 | 5.2328 | -17.8401 | QC'd by "SigmaAldrich" | |||||||||
| Inactive | 4 | 0 0 0 0 0 | -15.1256 | 6.2512 | -4.3289 | -0.9994 | 2.3229 | -15.1256 | QC'd by "SigmaAldrich" | |||||||||
| Inactive | 4 | -7.475 | -6.7939 | -8.3449 | -5.3761 | -5.806 | -7.475 | QC'd by "SigmaAldrich" | ||||||||||
| Inactive | 4 | 0 0 0 0 0 | 9.1001 | 25.677 | 10.5612 | 34.0633 | 37.5801 | 9.1001 | QC'd by "SigmaAldrich" | |||||||||
| Cytotoxic | 19.9526 | 117.3314 | Partial curve; high efficacy; poor fit | -4.7 | 0.9 | 0.9005 | -127.2239 | -9.8926 | -2.3 | 0 0 0 0 0 | -100.9714 | 3.1608 | -27.6796 | -30.9309 | -43.8285 | -100.9714 | QC'd by "SigmaAldrich" | |
| Inactive | 4 | 0 0 0 0 0 | -4.1328 | -1.1519 | 6.0784 | -3.0376 | 0.8686 | -4.1328 | QC'd by "SigmaAldrich" | |||||||||
| Cytotoxic | 39.8107 | 28.7208 | Partial curve; partial efficacy; poor fit | -4.4 | 3.6772 | 0.9911 | -35.9992 | -7.2784 | -2.4 | 0 0 0 0 0 | -29.9993 | -5.6487 | -7.8259 | -8.1414 | -7.5339 | -29.9993 | QC'd by "SigmaAldrich" | |
| Cytotoxic | 31.6228 | 97.2268 | Single point of activity | -4.5 | 2.0437 | 0.973 | -92.4117 | 4.8151 | -3 | 0 0 0 0 0 | -70.0089 | 13.6895 | 2.0458 | -1.2716 | -5.7764 | -70.0089 | QC'd by "SigmaAldrich" | |
| Inactive | 4 | 0 0 0 0 0 | -15.2145 | -2.8973 | -8.6565 | -5.5649 | -6.8877 | -15.2145 | QC'd by "SigmaAldrich" | |||||||||
| Cytotoxic | 28.1838 | 72.8012 | Single point of activity | -4.55 | 1.8579 | 0.9604 | -62.5145 | 10.2867 | -3 | 0 0 0 0 0 | -47.4509 | 18.2829 | 5.32 | 6.0934 | 0.2154 | -47.4509 | QC'd by "SigmaAldrich" | |
| Inactive | 4 | 0 0 0 0 0 | -27.5276 | -7.835 | -4.5068 | -11.5619 | -3.8922 | -27.5276 | QC'd by "SigmaAldrich" | |||||||||
| Inactive | 4 | 0 0 0 0 0 | 0.7905 | 18.0284 | 4.1591 | 10.4155 | 14.9325 | 0.7905 | QC'd by "SigmaAldrich" | |||||||||
| Inactive | 4 | 1 0 0 0 0 | -17.8147 | 24.7332 | 1.5663 | -0.1577 | 4.9397 | -17.8147 | QC'd by "SigmaAldrich" | |||||||||
| Cytotoxic | 15.8489 | 53.823 | Partial curve; partial efficacy | -4.8 | 1.111 | 0.9948 | -66.8063 | -12.9833 | -2.2 | 0 0 0 0 0 | -56.0886 | -14.5996 | -11.8947 | -19.2332 | -35.0535 | -56.0886 | QC'd by "SigmaAldrich" | |
| Cytotoxic | 7.0795 | 99.3408 | Single point of activity | -5.15 | 4.9549 | 0.992 | -101.8303 | -2.4895 | -3 | 0 0 0 0 1 | -39.6531 | 0.3061 | -8.0065 | 0.6081 | -94.2874 | -39.6531 | QC'd by "SigmaAldrich" | |
| Inactive | 4 | 0 0 0 0 0 | -20.8827 | -12.5354 | -16.3567 | -16.6681 | -12.1166 | -20.8827 | QC'd by "SigmaAldrich" | |||||||||
| Cytotoxic | 22.3872 | 99.0917 | Partial curve; high efficacy | -4.65 | 2.7202 | 0.9947 | -97.0716 | 2.0201 | -2.1 | 0 0 0 0 0 | -89.3845 | 5.4144 | -2.4263 | 3.2332 | -11.8203 | -89.3845 | QC'd by "SigmaAldrich" |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 64 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 58 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 31 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 4 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 18 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 28 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 61 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 84 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 12 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 33 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 63 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 19.6 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 67 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Activity | = | 26 | % |
| Phenotype | Potency | Efficacy | Analysis Comment | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.091 uM | Activity at 0.457 uM | Activity at 2.290 uM | Activity at 11.40 uM | Activity at 57.10 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 25.1189 | 32.3251 | Single point of activity | -4.6 | 2.2526 | 0.9519 | -37.3265 | -5.0013 | -3 | 0 0 0 0 0 | -32.7721 | -2.0845 | -9.4243 | -4.1966 | -9.8488 | -32.7721 | QC'd by "SigmaAldrich" | |
| Inhibitor | 15.8489 | 86.1551 | Partial curve; partial efficacy | -4.8 | 2.2526 | 0.9831 | -76.8113 | 9.3438 | -2.2 | 0 0 0 0 0 | -70.6903 | 12.0835 | 1.9513 | 12.4338 | -17.7233 | -70.6903 | QC'd by "SigmaAldrich" | |
| Inhibitor | 17.7828 | 48.1305 | Partial curve; partial efficacy | -4.75 | 2.4064 | 0.9751 | -31.5989 | 16.5316 | -2.2 | 0 0 0 0 0 | -28.8193 | 14.9752 | 13.3176 | 21.3387 | 3.9358 | -28.8193 | QC'd by "SigmaAldrich" | |
| Inactive | 4 | 0 0 0 0 0 | -6.6363 | 18.2144 | -12.0466 | 1.106 | 0.4089 | -6.6363 | QC'd by "SigmaAldrich" | |||||||||
| Inactive | 4 | 0 0 0 0 0 | -12.5356 | 4.3784 | -6.3143 | -0.9752 | 2.5146 | -12.5356 | QC'd by "SigmaAldrich" | |||||||||
| Inactive | 4 | 0 0 0 0 0 | 1.099 | -8.996 | 0.2771 | -1.7165 | -4.9277 | 1.099 | QC'd by "SigmaAldrich" | |||||||||
| Inactive | 4 | -2.5324 | 11.7092 | -5.338 | 16.9841 | 4.1492 | -2.5324 | QC'd by "SigmaAldrich" | ||||||||||
| Inhibitor | 0.1 | 62.2751 | Complete curve; high efficacy; poor fit | -7 | 3.6272 | 0.6023 | -80.9362 | -18.6611 | -1.3 | 0 0 0 0 0 | -96.3526 | -44.7427 | -80.7506 | -86.7134 | -60.3161 | -96.3526 | QC'd by "SigmaAldrich" | |
| Inactive | 4 | 0 0 0 0 0 | 11.1048 | -0.9478 | 10.1842 | -2.642 | -2.3029 | 11.1048 | QC'd by "SigmaAldrich" | |||||||||
| Inhibitor | 25.1189 | 38.4189 | Single point of activity | -4.6 | 3.0654 | 0.9347 | -37.0363 | 1.3826 | -3 | 0 0 0 0 0 | -34.0012 | -1.7871 | -1.6511 | 8.347 | -1.9146 | -34.0012 | QC'd by "SigmaAldrich" | |
| Inhibitor | 28.1838 | 81.8981 | Single point of activity | -4.55 | 3.0654 | 0.9956 | -86.0465 | -4.1484 | -3 | 0 0 0 0 0 | -77.6867 | -1.7089 | -7.5724 | -3.1708 | -9.097 | -77.6867 | QC'd by "SigmaAldrich" | |
| Inactive | 4 | 0 0 0 0 0 | -25.5241 | -2.3053 | -3.3901 | 18.5124 | -3.8247 | -25.5241 | QC'd by "SigmaAldrich" | |||||||||
| Inhibitor | 14.1254 | 63.2086 | Partial curve; partial efficacy | -4.85 | 2.4064 | 0.997 | -57.2086 | 6 | -2.2 | 0 0 0 0 0 | -56.0868 | 6.9914 | 3.6249 | 5.298 | -16.6421 | -56.0868 | QC'd by "SigmaAldrich" | |
| Inactive | 4 | 0 0 0 0 0 | -6.4413 | -5.1065 | 2.3605 | 3.099 | 2.5399 | -6.4413 | QC'd by "SigmaAldrich" | |||||||||
| Inactive | 4 | 7.6671 | 12.951 | 0.9859 | 7.263 | 13.989 | 7.6671 | QC'd by "SigmaAldrich" | ||||||||||
| Inactive | 4 | 0 0 0 0 1 | 14.805 | 15.872 | -3.6668 | 19.3074 | 22.4188 | 14.805 | QC'd by "SigmaAldrich" | |||||||||
| Inactive | 4 | 0 0 0 0 0 | 7.2744 | -8.4147 | -8.0803 | -9.3101 | -8.653 | 7.2744 | QC'd by "SigmaAldrich" | |||||||||
| Inhibitor | 4.4668 | 81.1301 | Complete curve; high efficacy; poor fit | -5.35 | 4.9549 | 0.9504 | -82.3177 | -1.1877 | -1.3 | 0 0 0 0 0 | -68.2561 | -0.1456 | -3.7369 | -2.3223 | -95.2752 | -68.2561 | QC'd by "SigmaAldrich" | |
| Inactive | 4 | 0 0 0 0 0 | -14.833 | -9.0881 | -9.8183 | -8.0979 | -11.1419 | -14.833 | QC'd by "SigmaAldrich" | |||||||||
| Inhibitor | 15.8489 | 106.7713 | Partial curve; high efficacy | -4.8 | 2.2526 | 0.9896 | -102.0021 | 4.7692 | -2.1 | 0 0 0 0 0 | -96.0471 | 9.9358 | -2.0726 | 5.7106 | -31.0661 | -96.0471 | QC'd by "SigmaAldrich" |
| Phenotype | Potency | Efficacy | Analysis Comment | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0005900000 uM | Activity at 0.00295 uM | Activity at 0.015 uM | Activity at 0.074 uM | Activity at 0.369 uM | Activity at 1.840 uM | Activity at 9.220 uM | Activity at 46.10 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 4 | 0 0 0 0 0 0 0 1 | -2.8899 | -6.1899 | -7.5624 | -5.0442 | -5.2691 | -7.4083 | -3.0625 | 0.8337 | -2.8899 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 0 | -11.886 | 0.7799 | 3.3283 | -1.6574 | -0.379 | -0.0407 | -0.1733 | 3.2895 | -11.886 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | -8.0307 | 0.0881 | -3.9451 | -3.8178 | -5.1347 | -11.9909 | -2.936 | -1.1932 | -8.0307 | QC'd by "Tocris" | ||||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 0 | -1.593 | 1.5561 | 0.9032 | 1.2235 | -3.4696 | -0.9657 | -0.0842 | -2.0495 | -1.593 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 0 | -0.0788 | -4.9337 | 0.46 | -2.5807 | 0.7446 | 0.0136 | -2.3008 | -1.5552 | -0.0788 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 1 | 4.2624 | -0.4312 | 1.7854 | -0.0056 | 5.8662 | 1.0675 | -7.8806 | 1.2475 | 4.2624 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 1 | -4.0346 | -8.947 | -0.9086 | -0.5189 | -7.1836 | -5.169 | -5.6634 | -29.5845 | -4.0346 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 0 | 5.7591 | -1.4068 | 2.7508 | -0.1815 | 2.9785 | 3.694 | 3.9998 | -0.3015 | 5.7591 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 1 | -5.3844 | 2.4078 | -5.9512 | -3.7241 | -3.3992 | 2.057 | 0.6331 | 0.8532 | -5.3844 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 0 | -2.2453 | -3.7363 | 0.6942 | 0.601 | -1.9285 | -1.3609 | 4.3516 | 1.1697 | -2.2453 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 1 | 2.3324 | -0.5355 | 0.1243 | 4.3039 | 4.1456 | 6.6613 | 3.3936 | 4.3321 | 2.3324 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 1 | 6.7977 | 6.2063 | -2.5612 | -1.1693 | -0.5128 | 0.1248 | -0.3521 | 0.7397 | 6.7977 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 0 | 2.0217 | -0.1792 | 0.1152 | -0.6021 | -3.3605 | 0.8237 | 4.5925 | -1.2217 | 2.0217 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 1 | 0.4425 | 0.3833 | -4.4422 | -0.573 | -2.932 | 1.0594 | 0.9653 | -13.9348 | 0.4425 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | -3.4074 | -6.9944 | -1.6722 | 0.3863 | -3.9812 | 2.4758 | -6.1635 | -1.5512 | -3.4074 | QC'd by "Tocris" | ||||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 1 | -4.3806 | -4.5738 | -3.6173 | -2.0174 | 0.1354 | -5.2732 | -8.3845 | -9.4028 | -4.3806 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 0 | -2.4802 | -2.104 | 1.6816 | 1.3442 | 3.6776 | 3.5172 | -1.5608 | -3.0137 | -2.4802 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 1 | -0.8776 | 1.878 | -0.0634 | 4.212 | -1.1416 | 4.9935 | -0.0837 | -6.743 | -0.8776 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 1 | 2.0095 | 0.0313 | -0.3445 | -1.2227 | -5.0231 | -0.664 | 1.2992 | -8.0246 | 2.0095 | QC'd by "Tocris" | |||||||||
| Inactive | 4 | 0 0 0 0 0 0 0 1 | -0.554 | -4.5098 | -3.3182 | -1.7265 | -0.7027 | -6.0998 | -4.6423 | -10.6714 | -0.554 | QC'd by "Tocris" |
| Phenotype-Replicate_1 | Potency-Replicate_1 | Efficacy-Replicate_1 | Analysis Comment-Replicate_1 | Activity_Score-Replicate_1 | Curve_Description-Replicate_1 | Fit_LogAC50-Replicate_1 | Fit_HillSlope-Replicate_1 | Fit_R2-Replicate_1 | Fit_InfiniteActivity-Replicate_1 | Fit_ZeroActivity-Replicate_1 | Fit_CurveClass-Replicate_1 | Excluded_Points-Replicate_1 | Max_Response-Replicate_1 | Activity at 0.0005899000 uM-Replicate_1 | Activity at 0.00118 uM-Replicate_1 | Activity at 0.00295 uM-Replicate_1 | Activity at 0.00590 uM-Replicate_1 | Activity at 0.015 uM-Replicate_1 | Activity at 0.029 uM-Replicate_1 | Activity at 0.074 uM-Replicate_1 | Activity at 0.148 uM-Replicate_1 | Activity at 0.369 uM-Replicate_1 | Activity at 0.737 uM-Replicate_1 | Activity at 1.843 uM-Replicate_1 | Activity at 3.687 uM-Replicate_1 | Activity at 9.217 uM-Replicate_1 | Activity at 18.43 uM-Replicate_1 | Activity at 46.08 uM-Replicate_1 | Activity at 92.17 uM-Replicate_1 | Compound QC-Replicate_1 | Phenotype-Replicate_2 | Potency-Replicate_2 | Efficacy-Replicate_2 | Analysis Comment-Replicate_2 | Activity_Score-Replicate_2 | Curve_Description-Replicate_2 | Fit_LogAC50-Replicate_2 | Fit_HillSlope-Replicate_2 | Fit_R2-Replicate_2 | Fit_InfiniteActivity-Replicate_2 | Fit_ZeroActivity-Replicate_2 | Fit_CurveClass-Replicate_2 | Excluded_Points-Replicate_2 | Max_Response-Replicate_2 | Activity at 0.0005899000 uM-Replicate_2 | Activity at 0.00118 uM-Replicate_2 | Activity at 0.00295 uM-Replicate_2 | Activity at 0.00590 uM-Replicate_2 | Activity at 0.015 uM-Replicate_2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -8.6137 | 2.0937 | 0.721 | 0 | -9.3472 | 4 | 0 0 0 0 0 0 0 0 | -1.1981 | -7.7893 | -1.3061 | -0.9136 | 2.7218 | -2.4449 | 2.3491 | 0.5984 | -1.1981 | QC'd by Enamine | Inactive | 0 | 0 | 0 | 4 | -2.1799 | -5.7621 | -6.6695 | |||||||||||||||||||||||
| Inactive | 0 | -5.7637 | 4.9549 | 0.7632 | -7.8669 | 0 | 4 | 0 0 0 0 0 0 0 0 | -9.7072 | 0.1194 | 0.8287 | -2.1801 | -1.2549 | 3.4297 | -9.8891 | -4.5089 | -9.7072 | QC'd by Enamine | Inactive | 0 | -4.2137 | 3.2475 | 0.7579 | -22.3272 | -2 | 4 | 0 0 0 0 0 0 0 0 | -18.1894 | -7.6164 | -4.6343 | |||||||||||||||||||
| Cytotoxic | 48.5577 | 32.5806 | 20 | Single point of activity | -4.3137 | 3.2975 | 0.9389 | -34.0806 | -1.5 | -3 | 0 0 0 0 0 0 0 0 | -30.4839 | 2.0077 | 1.2353 | -4.12 | -5.6743 | -2.5921 | -0.0827 | -2.7826 | -30.4839 | QC'd by Enamine | Inactive | 0 | -4.4637 | 2.9023 | 0.9774 | -26.7175 | -0.5 | 4 | 0 0 0 0 0 0 0 0 | -25.1812 | -1.3717 | 1.1119 | ||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -4.0244 | -1.5815 | 0.5532 | 1.8696 | 0.2877 | -1.0948 | -0.9718 | 1.3168 | -4.0244 | QC'd by Enamine | Inactive | 0 | 0 | 0 | 4 | 2.6212 | -1.3633 | 1.1082 | |||||||||||||||||||||||||||
| Inactive | 0 | -4.3137 | 1 | 0.6075 | -12.9835 | -1.5 | 4 | 0 0 0 0 0 0 0 0 | -9.1529 | -6.2602 | 0.8875 | -0.2672 | -1.0757 | -1.1078 | -3.3998 | -4.2513 | -9.1529 | QC'd by SIGMA | Inactive | 0 | -4.1637 | 4.4495 | 0.8449 | -13.8135 | -1 | 4 | 0 0 0 0 0 0 0 0 | -11.0946 | -2.2814 | -1.8218 | |||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.2635 | -3.2218 | -1.5002 | -3.2094 | -6.5467 | -6.9838 | -9.2586 | -2.3579 | -2.2635 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | -2.1934 | -6.1949 | -2.9926 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -3.6053 | -10.98 | -3.1918 | -5.1884 | -6.2628 | -0.9809 | -3.7687 | -3.2149 | -3.6053 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | -2.2311 | -5.312 | 1.6461 | |||||||||||||||||||||||||||
| Cytotoxic | 48.5577 | 49.8834 | 20 | Single point of activity | -4.3137 | 3.2975 | 0.9731 | -52.7952 | -2.9118 | -3 | 0 0 0 0 0 0 0 0 | -47.5721 | -5.7276 | -1.7088 | 0.0712 | 1.5459 | -4.3172 | -5.7565 | -4.7314 | -47.5721 | QC'd by SIGMA | Cytotoxic | 68.5896 | 55.547 | 20 | Single point of activity | -4.1637 | 3.99 | 0.9932 | -57.6622 | -2.1152 | -3 | 0 0 0 0 0 0 0 0 | -44.4411 | -3.0449 | -2.577 | |||||||||||||
| Inactive | 0 | -6.3637 | 0.2 | 0.6099 | 8 | -9.6563 | 4 | 0 0 0 0 0 0 0 0 | 5.2888 | -8.0469 | -2.1533 | 0.5824 | -6.716 | 0.5639 | 0.8956 | 1.5985 | 5.2888 | QC'd by SIGMA | Inactive | 0 | -5.2637 | 1.2221 | 0.9111 | -12.426 | 2 | 4 | 0 0 0 0 0 0 0 1 | 5.0335 | -0.899 | 2.8828 | |||||||||||||||||||
| Inactive | 0 | -4.1637 | 4.4495 | 0.8402 | -12.6467 | 0 | 4 | 0 0 0 0 0 0 0 0 | -10.1223 | -1.3467 | 1.9663 | -1.5401 | 2.2503 | -0.6504 | -1.3957 | 1.3844 | -10.1223 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | -5.9601 | -4.8718 | -1.2894 | |||||||||||||||||||||||
| Inactive | 0 | -7.0637 | 4.9549 | 0.7513 | -8.9661 | 2.5 | 4 | 0 0 0 0 0 0 0 0 | -15.3884 | 0.706 | 2.9045 | 3.3353 | -8.2144 | -8.9894 | -9.0163 | -3.1514 | -15.3884 | QC'd by SIGMA | Inactive | 0 | -4.3637 | 3.6272 | 0.923 | -19.7708 | 0.5 | 4 | 0 0 0 0 0 0 0 0 | -18.559 | 2.3106 | -3.7006 | |||||||||||||||||||
| Cytotoxic | 43.2771 | 75.6324 | 20 | Single point of activity | -4.3637 | 3.2975 | 0.9904 | -76.4078 | -0.7754 | -3 | 0 0 0 0 0 0 0 0 | -70.3847 | 1.9902 | 2.3693 | -0.9536 | -1.7116 | -0.7698 | -5.276 | -6.3803 | -70.3847 | QC'd by SIGMA | Cytotoxic | 48.5577 | 82.7194 | 20 | Single point of activity | -4.3137 | 3.2975 | 0.9843 | -85.6388 | -2.9194 | -3 | 0 0 0 0 0 0 0 0 | -76.6203 | -7.7845 | -4.8132 | |||||||||||||
| Inactive | 0 | -4.4137 | 0.7 | 0.7291 | -12.603 | 1 | 4 | 0 0 0 0 0 0 0 0 | -8.8358 | 0.5447 | -0.2742 | 2.4902 | 0.8744 | 1.9273 | -4.8205 | -1.4703 | -8.8358 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | -3.8112 | -0.6122 | -0.8775 | |||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -4.7292 | -2.4847 | -4.1876 | -6.4867 | 1.0395 | -0.7162 | 0.0299 | -0.793 | -4.7292 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | 2.6314 | 0.3943 | -1.3136 | |||||||||||||||||||||||||||
| Inactive | 0 | -5.8137 | 1.6436 | 0.8047 | 0.5 | -6.4974 | 4 | 0 0 0 0 0 0 0 0 | -0.4266 | -9.1645 | -5.8022 | -3.6937 | -7.1147 | -4.6312 | -0.9477 | 1.1703 | -0.4266 | QC'd by SIGMA | Inactive | 0 | -4.3137 | 4.5045 | 0.8295 | 13.5 | -1.9653 | 4 | 0 0 0 0 0 0 0 0 | 12.7252 | -3.6822 | 1.1451 | |||||||||||||||||||
| Cytotoxic | 24.3365 | 49.0952 | 40 | Partial curve; partial efficacy | -4.6137 | 4.5045 | 0.9503 | -50.0798 | -0.9846 | -2.2 | 0 0 0 0 0 0 0 0 | -50.0782 | -0.027 | 2.3579 | -4.7322 | -0.1367 | 4.7681 | -8.001 | -12.0828 | -50.0782 | QC'd by SIGMA | Cytotoxic | 34.3762 | 51.395 | 20 | Partial curve; partial efficacy | -4.4637 | 1.6604 | 0.9408 | -52.4652 | -1.0701 | -2.2 | 0 0 0 0 0 0 0 0 | -46.0221 | 0.2528 | 0.4999 | |||||||||||||
| Inactive | 0 | -5.8637 | 4.9549 | 0.5635 | -7.1429 | -1 | 4 | 0 0 0 0 0 0 0 1 | 1.7155 | -3.0936 | -3.8627 | 1.0831 | 0.1892 | -0.7274 | -10.5357 | -4.0515 | 1.7155 | QC'd by LightBiologicals | Inactive | 0 | 0 | 0 | 4 | 1.3344 | -8.4864 | -3.5514 | |||||||||||||||||||||||
| Inactive | 0 | -8.0137 | 4.9549 | 0.8219 | -1.5 | -15.3837 | 4 | 0 0 0 0 0 0 0 0 | -0.1642 | -15.3198 | -14.4981 | 0.2013 | -6.924 | 2.4229 | -4.1823 | 0 | -0.1642 | QC'd by SIGMA | Inactive | 0 | -5.0137 | 4.9549 | 0.4131 | 5 | -2.5442 | 4 | 0 0 0 0 0 0 0 0 | 3.8807 | 0.3165 | 2.8847 | |||||||||||||||||||
| Inactive | 0 | -7.9637 | 4.9549 | 0.6746 | -2.3322 | 7 | 4 | 0 0 0 0 0 0 0 1 | 7.5781 | 5.9636 | 7.5271 | -8.1935 | -0.71 | 0.9919 | -1.6782 | -0.8604 | 7.5781 | QC'd by SIGMA | Inactive | 0 | -6.1137 | 2.7202 | 0.8487 | 6 | -3.0675 | 4 | 0 0 0 0 0 0 0 0 | 6.1795 | -3.1652 | -6.3062 | |||||||||||||||||||
| Cytotoxic | 43.2771 | 30.719 | 20 | Partial curve; partial efficacy; poor fit | -4.3637 | 1.4641 | 0.9032 | -33.219 | -2.5 | -2.4 | 0 0 0 0 0 0 0 0 | -27.6825 | -1.9081 | -4.6287 | -2.873 | -0.3761 | 0.9727 | -8.0988 | -6.6948 | -27.6825 | QC'd by SIGMA | Inactive | 0 | -4.7637 | 1.8851 | 0.9867 | -25.4518 | -0.5 | 4 | 0 0 0 0 0 0 0 0 | -24.5432 | -1.778 | 0.5931 |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| FC | = | 1.6 |
| Phenotype-Replicate_1 | Potency-Replicate_1 | Efficacy-Replicate_1 | Analysis Comment-Replicate_1 | Activity_Score-Replicate_1 | Curve_Description-Replicate_1 | Fit_LogAC50-Replicate_1 | Fit_HillSlope-Replicate_1 | Fit_R2-Replicate_1 | Fit_InfiniteActivity-Replicate_1 | Fit_ZeroActivity-Replicate_1 | Fit_CurveClass-Replicate_1 | Excluded_Points-Replicate_1 | Max_Response-Replicate_1 | Activity at 0.0005899000 uM-Replicate_1 | Activity at 0.00118 uM-Replicate_1 | Activity at 0.00295 uM-Replicate_1 | Activity at 0.00590 uM-Replicate_1 | Activity at 0.015 uM-Replicate_1 | Activity at 0.029 uM-Replicate_1 | Activity at 0.074 uM-Replicate_1 | Activity at 0.148 uM-Replicate_1 | Activity at 0.369 uM-Replicate_1 | Activity at 0.737 uM-Replicate_1 | Activity at 1.843 uM-Replicate_1 | Activity at 3.687 uM-Replicate_1 | Activity at 9.217 uM-Replicate_1 | Activity at 18.43 uM-Replicate_1 | Activity at 46.08 uM-Replicate_1 | Activity at 92.17 uM-Replicate_1 | Compound QC-Replicate_1 | Phenotype-Replicate_2 | Potency-Replicate_2 | Efficacy-Replicate_2 | Analysis Comment-Replicate_2 | Activity_Score-Replicate_2 | Curve_Description-Replicate_2 | Fit_LogAC50-Replicate_2 | Fit_HillSlope-Replicate_2 | Fit_R2-Replicate_2 | Fit_InfiniteActivity-Replicate_2 | Fit_ZeroActivity-Replicate_2 | Fit_CurveClass-Replicate_2 | Excluded_Points-Replicate_2 | Max_Response-Replicate_2 | Activity at 0.0005899000 uM-Replicate_2 | Activity at 0.00118 uM-Replicate_2 | Activity at 0.00295 uM-Replicate_2 | Activity at 0.00590 uM-Replicate_2 | Activity at 0.015 uM-Replicate_2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -6.7137 | 3.99 | 0.7448 | 3.5 | -3.0979 | 4 | 0 0 0 0 0 0 0 1 | -4.5301 | 0.5359 | -3.9754 | -6.3316 | -1.534 | 3.7028 | 3.0225 | 3.9166 | -4.5301 | QC'd by Enamine | Inactive | 0 | -4.3637 | 4.5045 | 0.8609 | 20.5 | -2.0014 | 4 | 0 0 0 0 0 0 0 0 | 19.7998 | 1.4656 | -7.5012 | |||||||||||||||||||
| Inhibitor | 38.5708 | 35.1806 | 10 | Partial curve; partial efficacy; poor fit | -4.4137 | 0.3 | 0.5495 | -40.7918 | -5.6112 | -2.4 | 0 0 0 0 0 0 0 0 | -30.6598 | -14.2189 | -5.7598 | -1.3427 | -19.1905 | -11.1974 | -18.7235 | -15.3163 | -30.6598 | QC'd by Enamine | Inactive | 0 | -8.7637 | 4.9549 | 0.5011 | -5.7381 | 2 | 4 | 0 0 0 0 0 0 0 0 | -4.7769 | 0.9052 | -7.1733 | ||||||||||||||||
| Inhibitor | 43.2771 | 77.032 | 10 | Single point of activity | -4.3637 | 3.2975 | 0.9971 | -78.3429 | -1.3109 | -3 | 0 0 0 0 0 0 0 0 | -72.2295 | -0.848 | -0.118 | -4.2082 | -0.6518 | -1.8942 | -0.08 | -5.3518 | -72.2295 | QC'd by Enamine | Inhibitor | 43.2771 | 63.6484 | 10 | Single point of activity | -4.3637 | 2.9523 | 0.9946 | -65.7144 | -2.0659 | -3 | 0 0 0 0 0 0 0 0 | -59.6321 | -2.3181 | 1.0274 | |||||||||||||
| Inactive | 0 | -4.6137 | 4.095 | 0.7785 | -11.2649 | 0 | 4 | 0 0 0 0 0 0 0 0 | -11.0541 | 2.3776 | 0.4094 | 0.2158 | -4.5829 | 0.0109 | 1.9949 | -2.9254 | -11.0541 | QC'd by Enamine | Inactive | 0 | -4.4137 | 3.9295 | 0.7033 | -11.88 | -1 | 4 | 0 0 0 0 0 0 0 0 | -11.5667 | 0.631 | 2.2683 | |||||||||||||||||||
| Inhibitor | 13.6854 | 30.7075 | 21 | Partial curve; partial efficacy | -4.8637 | 1.331 | 0.9362 | -34.9705 | -4.2631 | -2.2 | 0 0 0 0 0 0 0 0 | -32.0588 | -3.9769 | -3.3008 | -9.2624 | -0.6359 | -6.9717 | -5.8106 | -24.2995 | -32.0588 | QC'd by SIGMA | Inhibitor | 19.3312 | 44.7107 | 20 | Partial curve; partial efficacy | -4.7137 | 4.9549 | 0.9424 | -44.0673 | 0.6434 | -2.2 | 0 0 0 0 0 0 0 0 | -43.9187 | 3.3929 | -7.8909 | |||||||||||||
| Inactive | 0 | -4.6137 | 0.5 | 0.8628 | 1.139 | -21.2073 | 4 | 0 0 0 0 0 0 0 0 | -4.0509 | -23.9228 | -19.6932 | -21.9663 | -17.0189 | -16.3805 | -16.3485 | -13.4943 | -4.0509 | QC'd by SIGMA | Inactive | 0 | -4.5637 | 0.6 | 0.8623 | 2.9723 | -21.7435 | 4 | 0 0 0 0 0 0 0 0 | -2.5231 | -21.0888 | -19.8358 | |||||||||||||||||||
| Inactive | 0 | -4.6637 | 4.095 | 0.7922 | -16.0186 | 7 | 4 | 0 0 0 0 0 0 0 0 | -15.4322 | 2.4951 | 11.0046 | 8.4138 | 12.5339 | -0.0246 | 8.6463 | -1.6168 | -15.4322 | QC'd by SIGMA | Inactive | 0 | -4.1637 | 4.9549 | 0.6395 | -12.122 | 5 | 4 | 0 0 0 0 0 0 0 0 | -8.8517 | 10.9119 | 2.0118 | |||||||||||||||||||
| Inhibitor | 43.2771 | 76.0133 | 10 | Single point of activity | -4.3637 | 3.2975 | 0.9556 | -72.6246 | 3.3888 | -3 | 0 0 0 0 0 0 0 0 | -67.0017 | 0.4321 | 2.2729 | 4.1028 | 15.2231 | -2.7033 | 0.1771 | -0.4468 | -67.0017 | QC'd by SIGMA | Inhibitor | 68.5896 | 78.0615 | 10 | Single point of activity | -4.1637 | 4.9549 | 0.8832 | -73.1865 | 4.8751 | -3 | 0 0 0 0 0 0 0 0 | -58.3846 | -2.614 | -4.3734 | |||||||||||||
| Activator | 1.2197 | 32.6844 | 0 | Complete curve; partial efficacy; poor fit | -5.9137 | 0.8 | 0.9481 | 30.5 | -2.1844 | 1.4 | 0 0 0 0 0 0 0 0 | 29.0103 | -1.6483 | 1.5958 | -4.3203 | 1.8363 | 14.8352 | 16.6478 | 29.694 | 29.0103 | QC'd by SIGMA | Activator | 48.5577 | 44.594 | 0 | Single point of activity | -4.3137 | 1 | 0.5389 | 47.7877 | 3.1937 | 3 | 0 0 0 0 0 0 0 0 | 38.0272 | 14.705 | 1.0969 | |||||||||||||
| Inactive | 0 | -4.6137 | 4.095 | 0.9713 | -21.2654 | -1.5 | 4 | 0 0 0 0 0 0 0 0 | -21.0545 | -2.7301 | -0.4134 | 1.0029 | -2.2409 | -1.0812 | -2.1276 | -6.3156 | -21.0545 | QC'd by SIGMA | Inactive | 0 | -4.4137 | 3.99 | 0.8429 | -24.4822 | 1.5 | 4 | 0 0 0 0 0 0 0 0 | -23.7352 | -0.6662 | -2.5056 | |||||||||||||||||||
| Activator | 17.2289 | 133.5992 | 0 | Partial curve; high efficacy | -4.7637 | 1.5579 | 0.9975 | 127.2961 | -6.3031 | 2.1 | 0 0 0 0 0 0 0 0 | 117.8667 | -8.9515 | -6.7202 | -3.1268 | -8.6465 | -1.6802 | 3.8092 | 64.311 | 117.8667 | QC'd by SIGMA | Activator | 21.6899 | 164.6248 | 0 | Partial curve; high efficacy | -4.6637 | 1.2475 | 0.9927 | 156.6074 | -8.0174 | 2.1 | 0 0 0 0 0 0 0 0 | 133.1695 | -7.9286 | -14.0417 | |||||||||||||
| Inhibitor | 68.5896 | 98.745 | 10 | Single point of activity | -4.1637 | 4.9549 | 0.931 | -122.9328 | -24.1879 | -3 | 0 0 0 0 0 0 0 0 | -104.5347 | -33.7189 | -31.4897 | -29.5277 | -32.0771 | -19.6494 | -24.4139 | -12.4858 | -104.5347 | QC'd by SIGMA | Inhibitor | 68.5896 | 65.978 | 10 | Single point of activity | -4.1637 | 4.4495 | 0.9656 | -93.0438 | -27.0659 | -3 | 0 0 0 0 0 0 0 0 | -79.0031 | -29.1044 | -30.014 | |||||||||||||
| Inactive | 0 | -4.1137 | 4.9549 | 0.6653 | -23.4729 | 1.5 | 4 | 0 0 0 0 0 0 0 0 | -16.2274 | 2.793 | 4.6828 | -5.1704 | -5.8825 | 3.4051 | 4.408 | 5.1222 | -16.2274 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | -8.3878 | -2.7507 | -9.7834 | |||||||||||||||||||||||
| Inactive | 0 | -6.9637 | 4.5045 | 0.5272 | 5 | -3.7817 | 4 | 0 0 0 0 0 0 0 0 | 12.2006 | -2.9898 | -3.919 | -4.8181 | 3.0282 | 9.0156 | -2.1288 | 1.7833 | 12.2006 | QC'd by SIGMA | Inactive | 0 | -4.6137 | 4.9549 | 0.81 | 10.5 | -1.3396 | 4 | 0 0 0 0 0 0 0 0 | 10.6787 | 1.3266 | -2.2209 | |||||||||||||||||||
| Inactive | 0 | -4.8137 | 0.5 | 0.7902 | 22 | -1.8797 | 4 | 0 0 0 0 0 0 0 0 | 16.0881 | -1.9337 | -0.9491 | -0.2665 | -4.0664 | 8.7026 | 1.967 | 10.793 | 16.0881 | QC'd by SIGMA | Inactive | 0 | -4.8137 | 1.7885 | 0.5359 | 15.5 | -0.4829 | 4 | 0 0 0 0 0 0 0 0 | 14.811 | -5.4024 | 11.5478 | |||||||||||||||||||
| Activator | 5.4483 | 65.9096 | 0 | Complete curve; high efficacy | -5.2637 | 3.5117 | 0.9928 | 65.1288 | -0.7808 | 1.1 | 0 0 0 0 0 0 0 0 | 64.1278 | 3.4298 | -0.9076 | -4.3967 | -2.5952 | 1.4367 | 10.9347 | 65.6986 | 64.1278 | QC'd by SIGMA | Activator | 8.6349 | 121.1169 | 0 | Partial curve; high efficacy | -5.0637 | 1.1705 | 0.9968 | 115.9495 | -5.1674 | 2.1 | 0 0 0 0 0 0 0 0 | 108.5669 | -5.4351 | -5.5745 | |||||||||||||
| Inactive | 0 | -5.7137 | 4.9549 | 0.595 | -8.7497 | 0 | 4 | 0 0 0 0 0 0 0 1 | 5.4059 | -2.6152 | -3.8122 | -2.0963 | 4.499 | 4.406 | -9.7914 | -7.1473 | 5.4059 | QC'd by LightBiologicals | Inactive | 0 | -4.1137 | 4.9549 | 0.3408 | -10.3215 | 0 | 4 | 0 0 0 0 0 0 0 0 | -7.3513 | -4.3507 | 2.8856 | |||||||||||||||||||
| Inactive | 0 | -7.3137 | 1.2221 | 0.9525 | -1.4634 | -23.3512 | 4 | 0 0 0 0 0 0 0 1 | -12.6292 | -20.3271 | -25.7094 | -13.6954 | -6.9291 | -1.6842 | -1.5865 | -0.8028 | -12.6292 | QC'd by SIGMA | Inactive | 0 | -6.9637 | 2.4064 | 0.4996 | -15.2703 | 0 | 4 | 0 0 0 0 0 0 0 0 | -27.7252 | 1.4691 | -2.4748 | |||||||||||||||||||
| Activator | 5.4483 | 83.6669 | 0 | Complete curve; high efficacy; poor fit | -5.2637 | 1 | 0.9696 | 88.0301 | 4.3632 | 1.3 | 1 0 0 0 0 0 0 0 | 82.8726 | 36.4156 | 12.0788 | 1.2155 | -2.9612 | 20.5714 | 36.4132 | 70.1398 | 82.8726 | QC'd by SIGMA | Activator | 5.4483 | 159.3997 | 0 | Partial curve; high efficacy | -5.2637 | 0.5 | 0.9946 | 149.0275 | -10.3722 | 2.1 | 0 0 0 0 0 0 0 0 | 117.16 | -5.2091 | -4.8857 | |||||||||||||
| Inhibitor | 68.5896 | 52.7425 | 10 | Single point of activity | -4.1637 | 4.9549 | 0.7907 | -52.54 | 0.2025 | -3 | 0 0 0 0 0 0 0 0 | -42.826 | -0.1565 | 10.1488 | 3.0709 | -2.1032 | -5.5467 | -13.8781 | 9.2268 | -42.826 | QC'd by SIGMA | Inhibitor | 68.5896 | 48.0428 | 10 | Single point of activity | -4.1637 | 4.9549 | 0.7805 | -49.2366 | -1.1938 | -3 | 0 0 0 0 0 0 0 0 | -40.1164 | 1.4546 | -2.3883 |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| FC | = | 1.5 |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| FC | = | 1.9 |
| E8-FLuc (log2) | NSC number |
|---|---|
| -1.5512 | 607097 |
| -1.1885 | 71795 |
| -0.8227 | 86372 |
| -0.7024 | 5159 |
| -0.6855 | 158383 |
| -0.6622 | 114572 |
| -0.6617 | 657799 |
| -0.6466 | 14973 |
| -0.6453 | 172614 |
| -0.6247 | 88065 |
| -0.6211 | 90823 |
| -0.6145 | 77427 |
| -0.5704 | 85239 |
| -0.5515 | 63926 |
| -0.5439 | 639174 |
| -0.543 | 48521 |
| -0.5375 | 76024 |
| -0.5365 | 295473 |
| -0.5312 | 4928 |
| -0.5214 | 64111 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 100 | MIC | > | 100000 | nM |
| 100 | MIC | > | 100000 | nM |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| FC | = | 1.3 |
| Phenotype-Replicate_1 | Potency-Replicate_1 | Efficacy-Replicate_1 | Analysis Comment-Replicate_1 | Activity_Score-Replicate_1 | Curve_Description-Replicate_1 | Fit_LogAC50-Replicate_1 | Fit_HillSlope-Replicate_1 | Fit_R2-Replicate_1 | Fit_InfiniteActivity-Replicate_1 | Fit_ZeroActivity-Replicate_1 | Fit_CurveClass-Replicate_1 | Excluded_Points-Replicate_1 | Max_Response-Replicate_1 | Activity at 0.0005899000 uM-Replicate_1 | Activity at 0.00118 uM-Replicate_1 | Activity at 0.00295 uM-Replicate_1 | Activity at 0.00590 uM-Replicate_1 | Activity at 0.015 uM-Replicate_1 | Activity at 0.029 uM-Replicate_1 | Activity at 0.074 uM-Replicate_1 | Activity at 0.148 uM-Replicate_1 | Activity at 0.369 uM-Replicate_1 | Activity at 0.737 uM-Replicate_1 | Activity at 1.843 uM-Replicate_1 | Activity at 3.687 uM-Replicate_1 | Activity at 9.217 uM-Replicate_1 | Activity at 18.43 uM-Replicate_1 | Activity at 46.08 uM-Replicate_1 | Activity at 92.17 uM-Replicate_1 | Compound QC-Replicate_1 | Phenotype-Replicate_2 | Potency-Replicate_2 | Efficacy-Replicate_2 | Analysis Comment-Replicate_2 | Activity_Score-Replicate_2 | Curve_Description-Replicate_2 | Fit_LogAC50-Replicate_2 | Fit_HillSlope-Replicate_2 | Fit_R2-Replicate_2 | Fit_InfiniteActivity-Replicate_2 | Fit_ZeroActivity-Replicate_2 | Fit_CurveClass-Replicate_2 | Excluded_Points-Replicate_2 | Max_Response-Replicate_2 | Activity at 0.0005899000 uM-Replicate_2 | Activity at 0.00118 uM-Replicate_2 | Activity at 0.00295 uM-Replicate_2 | Activity at 0.00590 uM-Replicate_2 | Activity at 0.015 uM-Replicate_2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -4.8637 | 1.4781 | 0.78 | 5.5 | -8.0607 | 4 | 0 0 0 0 0 0 0 0 | 4.915 | -11.7172 | -10.2261 | -5.6747 | -3.2162 | -8.4895 | -6.4294 | 0.1212 | 4.915 | QC'd by Enamine | Inactive | 0 | -4.7137 | 4.9549 | 0.7149 | 6.5 | -4.1075 | 4 | 0 0 0 0 0 0 0 0 | 6.3707 | -4.6171 | -5.2048 | |||||||||||||||||||
| Inactive | 0 | -6.6637 | 4.9549 | 0.6015 | -3.7977 | 2 | 4 | 0 0 0 0 0 0 0 0 | -5.2849 | 0.791 | 0.9268 | 4.172 | 1.3686 | -5.4818 | 1.3153 | -6.0814 | -5.2849 | QC'd by Enamine | Inactive | 0 | -5.8137 | 4.9549 | 0.3563 | -3.9449 | 2 | 4 | 0 0 0 0 0 0 0 0 | -7.6502 | 4.1673 | 0.1723 | |||||||||||||||||||
| Cytotoxic | 0.7696 | 79.1269 | 86 | Complete curve; high efficacy | -6.1137 | 2.4064 | 0.989 | -80.2129 | -1.086 | -1.1 | 0 0 0 0 0 0 0 0 | -74.1102 | -5.396 | -2.9033 | -0.4466 | 2.7921 | -36.8956 | -82.6325 | -83.0675 | -74.1102 | QC'd by Enamine | Cytotoxic | 0.6859 | 77.8151 | 20 | Complete curve; high efficacy; poor fit | -6.1637 | 2.4064 | 0.9961 | -79.552 | -1.7369 | -1.3 | 1 0 0 0 0 0 0 0 | -75.8034 | -72.1781 | -1.7358 | |||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -3.6673 | -6.0811 | -7.2954 | -2.9298 | -5.4835 | -6.4501 | -0.8482 | -0.7681 | -3.6673 | QC'd by Enamine | Inactive | 0 | 0 | 0 | 4 | 1.9261 | -2.3973 | -1.7209 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.1053 | 3.4072 | -1.2031 | 2.5309 | -0.5178 | 0.1374 | 2.5247 | 0.3316 | 3.1053 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | 0.5895 | 0.0467 | -1.1307 | |||||||||||||||||||||||||||
| Inactive | 0 | -8.8137 | 4.9549 | 0.3082 | -4.4311 | 7 | 4 | 0 0 0 0 0 0 0 0 | -0.1287 | 4.6299 | -9.5259 | 1.8857 | 1.5028 | -8.8402 | -7.8944 | -7.173 | -0.1287 | QC'd by SIGMA | Inactive | 0 | -7.2137 | 4.9549 | 0.6151 | -5.4211 | 3.5 | 4 | 0 0 0 0 0 0 0 1 | 3.2741 | 4.4889 | 1.0958 | |||||||||||||||||||
| Inactive | 0 | -4.1137 | 4.9549 | 0.5878 | -11.9248 | -1 | 4 | 0 0 0 0 0 0 0 0 | -8.6874 | -2.6017 | -2.1396 | -4.8238 | -0.7809 | -0.2262 | 1.3256 | 2.5681 | -8.6874 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | -3.035 | 0.9522 | -1.0902 | |||||||||||||||||||||||
| Cytotoxic | 24.3365 | 46.2152 | 20 | Partial curve; partial efficacy | -4.6137 | 4.095 | 0.8819 | -45.8472 | 0.3681 | -2.2 | 0 0 0 0 0 0 0 0 | -45.4384 | 5.881 | -8.1203 | -9.1589 | 1.9871 | 4.5691 | 5.5262 | -10.7271 | -45.4384 | QC'd by SIGMA | Cytotoxic | 34.3762 | 35.9633 | 20 | Partial curve; partial efficacy; poor fit | -4.4637 | 1.1 | 0.6483 | -38.4633 | -2.5 | -2.4 | 0 0 0 0 0 0 0 0 | -30.3861 | 3.9144 | -10.9322 | |||||||||||||
| Inactive | 0 | -6.7137 | 3.99 | 0.8426 | -7.8874 | 4.5 | 4 | 0 0 0 0 0 0 0 0 | -2.8995 | 3.2347 | 5.8541 | 4.8413 | 1.1609 | -11.9895 | -9.9614 | -6.4748 | -2.8995 | QC'd by SIGMA | Inactive | 0 | -6.2137 | 4.9549 | 0.3993 | -9.8085 | -1 | 4 | 0 0 0 0 0 0 0 1 | -4.2361 | 1.0581 | 2.2314 | |||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -8.8762 | -5.923 | -4.3846 | -2.7844 | -3.0174 | -1.5782 | 0.4467 | 1.6153 | -8.8762 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | -2.6033 | -0.7522 | -0.3781 | |||||||||||||||||||||||||||
| Cytotoxic | 13.6854 | 31.1922 | 20 | Partial curve; partial efficacy; poor fit | -4.8637 | 4.095 | 0.987 | -28.6922 | 2.5 | -2.4 | 0 0 0 0 0 0 0 0 | -29.3269 | 1.051 | 0.8291 | 3.0248 | 5.1988 | 2.4454 | 0.8952 | -21.0544 | -29.3269 | QC'd by SIGMA | Cytotoxic | 30.6379 | 39.1754 | 20 | Single point of activity | -4.5137 | 2.6384 | 0.9942 | -36.6754 | 2.5 | -3 | 0 0 0 0 0 0 0 0 | -33.845 | 2.1352 | 2.347 | |||||||||||||
| Cytotoxic | 38.5708 | 79.7667 | 40 | Partial curve; high efficacy | -4.4137 | 2.6384 | 0.9853 | -84.0115 | -4.2449 | -2.1 | 0 0 0 0 0 0 0 0 | -76.5239 | -2.4554 | -4.4134 | 0.9249 | -10.1622 | -3.8808 | -5.616 | -14.7247 | -76.5239 | QC'd by SIGMA | Cytotoxic | 54.4827 | 85.0617 | 20 | Single point of activity | -4.2637 | 3.2475 | 0.9911 | -91.6046 | -6.5429 | -3 | 0 0 0 0 0 0 0 0 | -78.4884 | -7.7514 | -8.9605 | |||||||||||||
| Cytotoxic | 19.3312 | 37.876 | 20 | Partial curve; partial efficacy | -4.7137 | 1.6259 | 0.9556 | -35.9554 | 1.9206 | -2.2 | 0 0 0 0 0 0 0 0 | -33.2962 | 1.1258 | -0.2194 | 8.2922 | -0.9325 | 0.7345 | 0.067 | -16.4636 | -33.2962 | QC'd by SIGMA | Cytotoxic | 24.3365 | 37.7294 | 20 | Single point of activity | -4.6137 | 4.9549 | 0.9857 | -38.7294 | -1 | -3 | 0 0 0 0 0 0 0 0 | -38.4602 | -3.9414 | -2.1898 | |||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.4699 | 0.4231 | 1.1739 | 2.4494 | -2.3903 | -5.8621 | -2.7542 | 2.1121 | -2.4699 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | -2.214 | -1.4625 | -2.7485 | |||||||||||||||||||||||||||
| Inactive | 0 | -4.6637 | 4.095 | 0.7411 | 12.5 | -2.6799 | 4 | 0 0 0 0 0 0 0 0 | 12.3306 | -2.456 | -4.3783 | 0.7114 | -1.0027 | 0.4255 | -9.3166 | 2.9967 | 12.3306 | QC'd by SIGMA | Inactive | 0 | -4.1637 | 4.9549 | 0.9448 | 19.5 | 0.2673 | 4 | 0 0 0 0 0 0 0 0 | 15.7501 | -0.3604 | 1.1005 | |||||||||||||||||||
| Cytotoxic | 24.3365 | 30.0691 | 20 | Single point of activity | -4.6137 | 4.095 | 0.9268 | -30.5691 | -0.5 | -3 | 0 0 0 0 0 0 0 0 | -30.4742 | -6.1565 | -0.1506 | 4.9067 | -0.8949 | 0.097 | -0.2413 | -8.1828 | -30.4742 | QC'd by SIGMA | Cytotoxic | 30.6379 | 41.7343 | 20 | Single point of activity | -4.5137 | 3.2975 | 0.9593 | -36.2343 | 5.5 | -3 | 0 0 0 0 0 0 0 0 | -33.4016 | 6.8803 | 7.6192 | |||||||||||||
| Inactive | 0 | -5.8637 | 0.4 | 0.9019 | 6.5 | -8.1524 | 4 | 0 0 0 0 0 0 0 0 | 4.1776 | -6.9275 | -6.6426 | -8.0437 | -2.1876 | -0.6978 | -1.4072 | 3.4291 | 4.1776 | QC'd by LightBiologicals | Inactive | 0 | 0 | 0 | 4 | 6.6773 | -1.8814 | 0.4883 | |||||||||||||||||||||||
| Inactive | 0 | -4.6137 | 4.5045 | 0.9231 | 10 | 0.0777 | 4 | 0 0 0 0 0 0 0 0 | 10.0385 | -0.4861 | 2.253 | -0.5031 | 0.1597 | 0.9668 | -0.7686 | 2.3892 | 10.0385 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | 7.4959 | -0.5175 | -0.4627 | |||||||||||||||||||||||
| Inconclusive | 0.1536 | 32.6912 | 10 | Partial curve; partial efficacy; poor fit | -6.8137 | 0.2 | 0.9301 | 16 | -16.6912 | 2.4 | 0 0 0 0 0 0 0 0 | 11.0017 | -10.576 | -3.6335 | -2.6864 | -0.7838 | 3.3144 | 2.7405 | 6.3466 | 11.0017 | QC'd by SIGMA | Inactive | 0 | -5.0137 | 1.7529 | 0.6399 | 6.5 | -1.8564 | 4 | 0 0 0 0 0 0 0 0 | 6.2964 | -1.4173 | 0.4366 | ||||||||||||||||
| Cytotoxic | 48.5577 | 32.2382 | 20 | Partial curve; partial efficacy; poor fit | -4.3137 | 1.1 | 0.9013 | -36.0152 | -3.7769 | -2.4 | 0 0 0 0 0 0 0 0 | -26.6793 | -0.5468 | -5.0549 | -6.9535 | -0.2308 | -5.7352 | -8.0532 | -10.5038 | -26.6793 | QC'd by SIGMA | Inactive | 0 | -4.6137 | 1.4641 | 0.9003 | -22.7063 | -2.9147 | 4 | 0 0 0 0 0 0 0 0 | -20.1719 | -4.0675 | -2.6739 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 100 | MIC | > | 100000 | nM |
| 100 | MIC | > | 100000 | nM |
| Phenotype-Replicate_1 | Potency-Replicate_1 | Efficacy-Replicate_1 | Analysis Comment-Replicate_1 | Activity_Score-Replicate_1 | Curve_Description-Replicate_1 | Fit_LogAC50-Replicate_1 | Fit_HillSlope-Replicate_1 | Fit_R2-Replicate_1 | Fit_InfiniteActivity-Replicate_1 | Fit_ZeroActivity-Replicate_1 | Fit_CurveClass-Replicate_1 | Excluded_Points-Replicate_1 | Max_Response-Replicate_1 | Activity at 0.0005899000 uM-Replicate_1 | Activity at 0.00118 uM-Replicate_1 | Activity at 0.00295 uM-Replicate_1 | Activity at 0.00590 uM-Replicate_1 | Activity at 0.015 uM-Replicate_1 | Activity at 0.029 uM-Replicate_1 | Activity at 0.074 uM-Replicate_1 | Activity at 0.148 uM-Replicate_1 | Activity at 0.369 uM-Replicate_1 | Activity at 0.737 uM-Replicate_1 | Activity at 1.843 uM-Replicate_1 | Activity at 3.687 uM-Replicate_1 | Activity at 9.217 uM-Replicate_1 | Activity at 18.43 uM-Replicate_1 | Activity at 46.08 uM-Replicate_1 | Activity at 92.17 uM-Replicate_1 | Compound QC-Replicate_1 | Phenotype-Replicate_2 | Potency-Replicate_2 | Efficacy-Replicate_2 | Analysis Comment-Replicate_2 | Activity_Score-Replicate_2 | Curve_Description-Replicate_2 | Fit_LogAC50-Replicate_2 | Fit_HillSlope-Replicate_2 | Fit_R2-Replicate_2 | Fit_InfiniteActivity-Replicate_2 | Fit_ZeroActivity-Replicate_2 | Fit_CurveClass-Replicate_2 | Excluded_Points-Replicate_2 | Max_Response-Replicate_2 | Activity at 0.0005899000 uM-Replicate_2 | Activity at 0.00118 uM-Replicate_2 | Activity at 0.00295 uM-Replicate_2 | Activity at 0.00590 uM-Replicate_2 | Activity at 0.015 uM-Replicate_2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 2.4014 | 0.9759 | 0.3078 | 1.8904 | -1.3214 | 1.1138 | -1.6886 | -2.5788 | 2.4014 | QC'd by Enamine | Inactive | 0 | 0 | 0 | 4 | 2.2787 | -0.9694 | -3.8908 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.9424 | -0.1831 | -2.1441 | -0.8123 | 0.7356 | -2.795 | -3.3133 | -0.3073 | -2.9424 | QC'd by Enamine | Inactive | 0 | 0 | 0 | 4 | 1.5663 | -0.9898 | -2.1656 | |||||||||||||||||||||||||||
| Inhibitor | 1.9331 | 30.2505 | 0 | Complete curve; partial efficacy | -5.7137 | 4.9549 | 0.9884 | -32.7505 | -2.5 | -1.2 | 0 0 0 0 0 0 0 0 | -32.7088 | -2.9131 | -4.6477 | -3.9229 | -1.6022 | 0.1764 | -32.5182 | -31.28 | -32.7088 | QC'd by Enamine | Inhibitor | 2.169 | 35.3408 | 0 | Complete curve; partial efficacy; poor fit | -5.6637 | 4.9549 | 0.9534 | -35.2825 | 0.0583 | -1.4 | 1 0 0 0 0 0 0 0 | -36.4368 | -31.3574 | -4.1999 | |||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 4.2421 | -5.0069 | 1.1218 | -0.0147 | 1.4143 | -0.7153 | -1.8654 | -1.0879 | 4.2421 | QC'd by Enamine | Inactive | 0 | 0 | 0 | 4 | -2.4793 | -2.9079 | -3.184 | |||||||||||||||||||||||||||
| Inactive | 0 | -4.2137 | 3.99 | 0.5455 | -9.5512 | 0 | 4 | 0 0 0 0 0 0 0 0 | -7.9593 | -4.5488 | 4.5166 | 0.2512 | -0.7312 | -1.4819 | 1.47 | -0.0426 | -7.9593 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | -11.2315 | -5.6697 | -2.8914 | |||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -4.1758 | -2.8245 | -1.4451 | 0.5422 | -0.3307 | -1.0244 | 1.948 | 0.1256 | -4.1758 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | 1.6001 | -3.8564 | 1.804 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 4.3768 | -4.084 | -2.0739 | -1.1987 | -0.2477 | -0.4857 | -0.7398 | 3.0879 | 4.3768 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | 3.4197 | -0.147 | 0.119 | |||||||||||||||||||||||||||
| Inactive | 0 | -4.4137 | 4.045 | 0.787 | -9.44 | 1 | 4 | 0 0 0 0 0 0 0 0 | -9.1167 | -0.8807 | 4.7479 | -0.574 | 0.3676 | 1.5356 | -0.5661 | 0.5529 | -9.1167 | QC'd by SIGMA | Inactive | 0 | -4.1637 | 4.9549 | 0.9155 | -18.8168 | -0.5 | 4 | 0 0 0 0 0 0 0 0 | -15.264 | -3.6443 | 1.0791 | |||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 4.5684 | 0.7369 | 1.2152 | -0.4642 | -5.374 | 0.7893 | -5.2966 | -0.667 | 4.5684 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | 3.0771 | 1.5072 | -1.0121 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 5.8798 | 0.9788 | -0.8043 | -0.1683 | 0.5835 | -0.0087 | 0.8357 | -0.4308 | 5.8798 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | 3.003 | 4.6097 | -0.2019 | |||||||||||||||||||||||||||
| Inactive | 0 | -4.7137 | 0.931 | 0.9667 | 16 | -12.662 | 4 | 0 0 0 0 0 0 0 0 | 11.1718 | -11.0163 | -13.0889 | -15.135 | -12.7909 | -8.7096 | -8.7132 | 0.8549 | 11.1718 | QC'd by SIGMA | Inactive | 0 | -4.6637 | 4.095 | 0.968 | 19 | -8.2761 | 4 | 0 0 0 0 0 0 0 0 | 18.8245 | -9.1995 | -8.5885 | |||||||||||||||||||
| Inactive | 0 | -4.1637 | 4.9549 | 0.9451 | -31.7539 | -2.5 | 4 | 0 0 0 0 0 0 0 0 | -26.4616 | -3.7295 | -5.2291 | -3.0969 | -2.288 | -3.5247 | -2.3208 | 1.7484 | -26.4616 | QC'd by SIGMA | Inactive | 0 | -4.1637 | 4.9549 | 0.9334 | -30.6082 | -2.5 | 4 | 0 0 0 0 0 0 0 0 | -25.5069 | -2.7103 | -5.3426 | |||||||||||||||||||
| Inactive | 0 | -4.7137 | 4.9549 | 0.9407 | -8.8985 | 0 | 4 | 0 0 0 0 0 0 0 0 | -9.0821 | 0.3128 | -1.4378 | 0.2924 | -0.4192 | 0 | 1.586 | -4.053 | -9.0821 | QC'd by SIGMA | Inactive | 0 | -4.5137 | 0.8 | 0.6738 | -13.3555 | 1 | 4 | 0 0 0 0 0 0 0 0 | -9.4629 | 0.6379 | -2.0412 | |||||||||||||||||||
| Inactive | 0 | -8.4137 | 0.7 | 0.5837 | -1.0739 | 10 | 4 | 0 0 0 0 0 0 0 0 | 0.2982 | 7.4748 | 2.2392 | 2.1545 | 0.6818 | 0.246 | -6.3116 | 1.3558 | 0.2982 | QC'd by SIGMA | Inactive | 0 | -6.9137 | 4.9549 | 0.486 | -0.784 | 6 | 4 | 0 0 0 0 0 0 0 0 | 0.2172 | 3.7318 | 1.5014 | |||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.4014 | 0.9093 | -2.3514 | -1.26 | -1.532 | -1.0946 | -1.4276 | -1.3037 | -2.4014 | QC'd by SIGMA | Inactive | 0 | 0 | 0 | 4 | -0.9775 | -6.6823 | -0.2967 | |||||||||||||||||||||||||||
| Activator | 12.1972 | 42.8282 | 41 | Complete curve; partial efficacy | -4.9137 | 2.9523 | 0.9876 | 42.7435 | -0.0848 | 1.2 | 0 0 0 0 0 0 0 0 | 42.6198 | -2.2542 | -2.363 | 0.4008 | -0.3011 | 3.4469 | 3.2687 | 32.9444 | 42.6198 | QC'd by SIGMA | Activator | 15.3553 | 43.4192 | 21 | Partial curve; partial efficacy | -4.8137 | 1.4641 | 0.9046 | 46.6823 | 3.2631 | 2.2 | 0 0 0 0 0 0 0 0 | 43.8062 | 14.8809 | 1.3724 | |||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.3627 | -0.0701 | -2.0823 | 1.3683 | 0.0983 | 0.279 | 1.0733 | -2.8305 | 1.3627 | QC'd by LightBiologicals | Inactive | 0 | 0 | 0 | 4 | -0.9148 | 1.1123 | -2.0113 | |||||||||||||||||||||||||||
| Inactive | 0 | -4.6137 | 4.095 | 0.9366 | 10 | -2.5752 | 4 | 0 0 0 0 0 0 0 0 | 9.8552 | -1.1769 | -2.1967 | -4.1352 | -1.5482 | -4.2293 | -3.6529 | 0.5324 | 9.8552 | QC'd by SIGMA | Inactive | 0 | -4.1637 | 4.9549 | 0.9017 | 17.5 | -2.6215 | 4 | 0 0 0 0 0 0 0 0 | 13.8866 | -3.2503 | -5.5179 | |||||||||||||||||||
| Activator | 7.6959 | 44.9412 | 41 | Complete curve; partial efficacy | -5.1137 | 1.7529 | 0.9777 | 43.3726 | -1.5686 | 1.2 | 0 0 0 0 0 0 0 0 | 42.7055 | -6.7239 | -3.1749 | 1.0732 | -2.1893 | 3.3055 | 7.1127 | 35.9651 | 42.7055 | QC'd by SIGMA | Activator | 30.6379 | 38.3786 | 10 | Partial curve; partial efficacy; poor fit | -4.5137 | 0.9 | 0.8902 | 48.3786 | 10 | 2.4 | 1 1 1 0 0 0 0 0 | 38.6065 | 23.462 | 20.9144 | |||||||||||||
| Inactive | 0 | -5.8137 | 1.5579 | 0.9841 | -8.5398 | 1 | 4 | 0 0 0 0 0 0 0 1 | 1.167 | 1.75 | 1.3632 | 0.0535 | 0.9714 | -1.3806 | -6.7289 | -8.3665 | 1.167 | QC'd by SIGMA | Inactive | 0 | -5.5137 | 2.7202 | 0.8571 | -9.4462 | 0 | 4 | 0 0 0 0 0 0 0 1 | 2.6963 | 2.3122 | 1.1111 |